Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer

Steven P. Rowe, Scott P. Campbell, Margarita Mana-Ay, Zsolt Szabo, Mohamad E. Allaf, Kenneth J. Pienta, Martin G. Pomper, Ashley E. Ross and Michael A. Gorin
Journal of Nuclear Medicine January 2020, 61 (1) 58-61; DOI: https://doi.org/10.2967/jnumed.119.226514
Steven P. Rowe
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott P. Campbell
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margarita Mana-Ay
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsolt Szabo
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamad E. Allaf
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth J. Pienta
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin G. Pomper
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley E. Ross
3Texas Urology Specialists, Mary Crowley Cancer Research Center, Dallas, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Gorin
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 61 no. 1 58-61
DOI 
https://doi.org/10.2967/jnumed.119.226514
PubMed 
31201249

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 23, 2019
  • Accepted for publication June 3, 2019
  • Published online January 2, 2020.

Article Versions

  • previous version (June 14, 2019 - 10:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Steven P. Rowe1,2,
  2. Scott P. Campbell2,
  3. Margarita Mana-Ay2,
  4. Zsolt Szabo1,
  5. Mohamad E. Allaf2,
  6. Kenneth J. Pienta2,
  7. Martin G. Pomper1,2,
  8. Ashley E. Ross3 and
  9. Michael A. Gorin1,2
  1. 1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  2. 2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
  3. 3Texas Urology Specialists, Mary Crowley Cancer Research Center, Dallas, Texas
  1. For correspondence or reprints contact: Steven P. Rowe, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N. Caroline St. Baltimore, MD 21287. E-mail: srowe8{at}jhmi.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 60 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
    Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong, Austin R. Pantel, Steve Y. Cho, Kenneth L. Gage, Morand Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter R. Carroll, Barry A. Siegel
    Clinical Cancer Research 2021 27 13
  • Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
    Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon, Andrei Iagaru
    Journal of Nuclear Medicine 2020 61 4
  • The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Rang Wang, Guohua Shen, Mingxing Huang, Rong Tian
    Frontiers in Oncology 2021 11
  • Piflufolastat F 18: Diagnostic First Approval
    Susan J. Keam
    Molecular Diagnosis & Therapy 2021 25 5
  • Salvage therapy for prostate cancer after radical prostatectomy
    Nicholas G. Zaorsky, Jeremie Calais, Stefano Fanti, Derya Tilki, Tanya Dorff, Daniel E. Spratt, Amar U. Kishan
    Nature Reviews Urology 2021 18 11
  • Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
    Tanya B. Dorff, Vivek Narayan, Stephen J. Forman, Peter D. Zang, Joseph A. Fraietta, Carl H. June, Naomi B. Haas, Saul J. Priceman
    Clinical Cancer Research 2022 28 4
  • Enzymatic synthesis of fluorinated compounds
    Xinkuan Cheng, Long Ma
    Applied Microbiology and Biotechnology 2021 105 21-22
  • Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml
    Ewa Witkowska-Patena, Agnieszka Giżewska, Mirosław Dziuk, Jolanta Miśko, Anna Budzyńska, Agata Walęcka-Mazur
    Prostate Cancer and Prostatic Diseases 2020 23 2
  • Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response
    Daria Klusa, Fabian Lohaus, Giulia Furesi, Martina Rauner, Martina Benešová, Mechthild Krause, Ina Kurth, Claudia Peitzsch
    Frontiers in Oncology 2021 10
  • Evaluation of 18F-DCFPyL PSMA PET/CT for Prostate Cancer: A Meta-Analysis
    Ke-Hao Pan, Jin-Feng Wang, Chun-Ying Wang, Abdul Aziz Nikzad, Fang Q. Kong, Li Jian, Yin-Qiu Zhang, Xiao-Ming Lu, Bin Xu, Ya-Li Wang, Ming Chen
    Frontiers in Oncology 2021 10

Article usage

Article usage: June 2019 to April 2025

AbstractFullPdf
Jun 2019466060
Jul 2019260032
Aug 201913807
Sep 2019115013
Oct 2019136020
Nov 201995013
Dec 201973018
Jan 2020118634102
Feb 2020270525
Mar 2020181316
Apr 2020132317
May 2020100212
Jun 202099023
Jul 20201021223
Aug 20201002453
Sep 20201433756
Oct 2020881529
Nov 2020621012
Dec 2020581224
Jan 2021303322
Feb 2021333221
Mar 2021403827
Apr 2021313320
May 2021233222
Jun 2021312521
Jul 2021212226
Aug 2021222522
Sep 2021352025
Oct 202181433
Nov 2021192346
Dec 2021193120
Jan 2022262620
Feb 2022131927
Mar 2022153334
Apr 2022152228
May 2022233338
Jun 2022142115
Jul 2022182617
Aug 2022262820
Sep 2022163433
Oct 2022132720
Nov 2022122114
Dec 2022131614
Jan 2023115017
Feb 202382920
Mar 202315248
Apr 202317613
May 202351315
Jun 202362113
Jul 20239105
Aug 2023121011
Sep 202381917
Oct 20237338
Nov 202312011
Dec 20232259
Jan 202418188
Feb 202441511
Mar 202441242
Apr 202447412
May 202435912
Jun 2024102712
Jul 202472823
Aug 2024164619
Sep 202483819
Oct 2024122920
Nov 20244179
Dec 202412411
Jan 20255197
Feb 2025164714
Mar 2025104829
Apr 202584231
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (1)
Journal of Nuclear Medicine
Vol. 61, Issue 1
January 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Steven P. Rowe, Scott P. Campbell, Margarita Mana-Ay, Zsolt Szabo, Mohamad E. Allaf, Kenneth J. Pienta, Martin G. Pomper, Ashley E. Ross, Michael A. Gorin
Journal of Nuclear Medicine Jan 2020, 61 (1) 58-61; DOI: 10.2967/jnumed.119.226514

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
Steven P. Rowe, Scott P. Campbell, Margarita Mana-Ay, Zsolt Szabo, Mohamad E. Allaf, Kenneth J. Pienta, Martin G. Pomper, Ashley E. Ross, Michael A. Gorin
Journal of Nuclear Medicine Jan 2020, 61 (1) 58-61; DOI: 10.2967/jnumed.119.226514
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • KEY POINTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
  • 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
  • Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
  • Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
  • Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
  • 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Show more Theranostics

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • oncology
  • Genitourinary
  • PET/CT
  • prostate-specific membrane antigen
  • biochemical persistence
  • biochemical recurrence
SNMMI

© 2025 SNMMI

Powered by HighWire